| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.64B | 1.31B | 1.02B | 578.84M | 392.15M |
| Gross Profit | 1.16B | 935.69M | 724.10M | 390.40M | 251.73M |
| EBITDA | 160.60M | 206.25M | 182.57M | 85.31M | 54.63M |
| Net Income | 54.60M | 112.09M | 127.66M | 61.53M | 21.77M |
Balance Sheet | |||||
| Total Assets | 2.39B | 1.25B | 1.13B | 595.60M | 494.63M |
| Cash, Cash Equivalents and Short-Term Investments | 289.69M | 148.69M | 108.18M | 120.78M | 43.35M |
| Total Debt | 916.90M | 313.02M | 290.60M | 82.17M | 117.00M |
| Total Liabilities | 1.26B | 487.32M | 486.68M | 184.58M | 182.20M |
| Stockholders Equity | 1.13B | 760.86M | 642.57M | 411.02M | 312.43M |
Cash Flow | |||||
| Free Cash Flow | 190.06M | 115.32M | 62.49M | 100.16M | 14.70M |
| Operating Cash Flow | 212.51M | 133.84M | 71.15M | 101.88M | 19.51M |
| Investing Cash Flow | -605.25M | -19.10M | -284.66M | -1.72M | -4.82M |
| Financing Cash Flow | 533.92M | -74.45M | 200.94M | -22.73M | -29.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $3.21B | 18.95 | 19.50% | 3.80% | 1.87% | 2.00% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $3.61B | 136.18 | 5.16% | ― | 24.59% | -76.41% | |
54 Neutral | $31.85B | -128.73 | -6.29% | 1.30% | 0.71% | 71.47% | |
53 Neutral | $997.66M | -12.94 | -5.14% | 3.51% | -5.30% | -196.78% | |
52 Neutral | $1.79B | -3.35 | -15.12% | ― | -3.57% | -32.30% | |
46 Neutral | $83.15M | -13.61 | -9.41% | ― | -8.16% | 85.14% |